Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
Netherlands (IPDGC) C UKPDSBB CL, PO 744 (36%) 2019 (64%) 56 (12) - - - 56 (6) - 9,595

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs12940071 chr17:45028052 GOSR2 C vs. T All: C 15 108,990 0.492 (C) 0.433 (C) 0.93 (0.90-0.96) 0 (0-43) 5.96e-06
rs3809854 chr17:45029294 GOSR2 C vs. T All: C 15 108,990 0.467 (C) 0.433 (C) 0.93 (0.90-0.96) 0 (0-49) 8.32e-06
rs17608961 chr17:45029668 GOSR2 G vs. T All: C 15 108,990 0.475 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-43) 6.14e-06
rs6504623 chr17:45031388 GOSR2 G vs. A All: C 15 108,990 - - 1.08 (1.05-1.12) 0 (0-43) 6.16e-06
rs4602097 chr17:45031830 GOSR2 C vs. T All: C 15 108,990 - - 1.08 (1.04-1.11) 0 (0-49) 7.55e-06
rs4381655 chr17:45032067 GOSR2 T vs. C All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-51) 2.45e-05
rs11651174 chr17:45032695 GOSR2 C vs. T All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-45) 1.49e-05
rs9303532 chr17:45034002 GOSR2 C vs. T All: C 15 108,990 0.442 (C) 0.367 (C) 0.93 (0.90-0.96) 0 (0-45) 1.48e-05
rs9912794 chr17:45034441 GOSR2 T vs. C All: C 15 108,990 0.442 (T) 0.35 (T) 0.93 (0.90-0.96) 0 (0-46) 2.17e-05
rs9911366 chr17:45034582 GOSR2 G vs. A All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-45) 1.54e-05
rs9898527 chr17:45036210 GOSR2 A vs. G All: C 15 108,990 0.442 (A) 0.367 (A) 0.93 (0.90-0.96) 0 (0-45) 1.55e-05
rs61671555 chr17:45037857 GOSR2 T vs. C All: C 15 108,990 0.433 (T) 0.367 (T) 0.93 (0.90-0.96) 0 (0-45) 1.62e-05
rs2316330 chr17:45040032 GOSR2 T vs. G All: C 15 108,990 0.458 (T) 0.433 (T) 0.93 (0.90-0.96) 0 (0-49) 7.28e-06
rs3851784 chr17:45040117 GOSR2 A vs. G All: C 15 108,990 0.442 (A) 0.433 (A) 0.93 (0.90-0.96) 0 (0-48) 2.14e-05
rs3851785 chr17:45040147 GOSR2 G vs. T All: C 15 108,990 0.467 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-48) 8.10e-06
rs11652318 chr17:45041094 GOSR2 C vs. T All: C 15 108,990 0.458 (C) 0.433 (C) 0.93 (0.90-0.96) 0 (0-48) 7.76e-06
rs3760377 chr17:45042079 GOSR2 G vs. A All: C 15 108,990 0.492 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-43) 5.03e-06
rs11079745 chr17:45044147 GOSR2 C vs. A All: C 15 108,990 0.492 (C) 0.425 (C) 0.93 (0.90-0.96) 0 (0-42) 4.65e-06
rs28451958 chr17:45045894 GOSR2 T vs. C All: C 15 108,990 0.442 (T) 0.433 (T) 0.93 (0.90-0.97) 0 (0-38) 1.25e-04
rs28553405 chr17:45045895 GOSR2 G vs. A All: C 15 108,990 0.458 (G) 0.433 (G) 0.92 (0.89-0.95) 0 (0-50) 7.99e-06
rs3851786 chr17:45046932 GOSR2 G vs. A All: C 15 108,990 0.458 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-42) 9.57e-06
rs3851787 chr17:45046982 GOSR2 G vs. A All: C 15 108,990 0.467 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-45) 7.72e-06
rs9893713 chr17:45047380 GOSR2 G vs. A All: C 15 108,990 0.475 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-40) 6.78e-06
rs4968290 chr17:45047384 GOSR2 C vs. T All: C 15 108,990 0.492 (C) 0.45 (C) 0.92 (0.89-0.96) 0 (0-33) 4.39e-06
rs7216991 chr17:45052253 GOSR2 G vs. A All: C 15 108,990 0.483 (G) 0.458 (G) 0.93 (0.90-0.96) 0 (0-52) 3.34e-06
rs62075896 chr17:45053590 GOSR2 C vs. T All: C 15 108,990 0.483 (C) 0.45 (C) 0.93 (0.90-0.96) 0 (0-52) 2.62e-06
rs8079694 chr17:45056928 GOSR2 C vs. T All: C 15 108,990 0.367 (C) 0.275 (C) 1.09 (1.05-1.13) 0 (0-52) 7.46e-06
rs8080518 chr17:45057481 GOSR2 C vs. T All: C 15 108,990 0.208 (C) - 0.93 (0.89-0.96) 0 (0-45) 6.07e-05
rs35246578 chr17:45062049 GOSR2 A vs. T All: C 15 108,990 0.367 (A) 0.158 (A) 1.10 (1.06-1.15) 0 (0-52) 8.19e-07
rs4572469 chr17:45064523 GOSR2 T vs. C All: C 15 108,990 - - 1.08 (1.04-1.11) 0 (0-51) 6.95e-06
rs3851798 chr17:45066267 GOSR2 G vs. A All: C 15 108,990 0.425 (G) 0.233 (A) 0.93 (0.90-0.96) 0 (0-51) 9.99e-06
rs2316758 chr17:45066365 GOSR2 C vs. T All: C 15 108,990 0.425 (C) 0.233 (T) 0.93 (0.90-0.96) 0 (0-50) 9.90e-06
rs3851799 chr17:45066488 GOSR2 T vs. C All: C 15 108,990 0.425 (T) 0.233 (C) 0.93 (0.90-0.96) 0 (0-50) 8.44e-06
rs11653589 chr17:45067665 GOSR2 C vs. T All: C 15 108,990 0.433 (C) 0.233 (T) 0.93 (0.90-0.96) 0 (0-50) 1.00e-05
rs8068715 chr17:45068388 GOSR2 A vs. C All: C 15 108,990 0.442 (A) 0.233 (C) 0.93 (0.90-0.96) 0 (0-50) 1.03e-05
rs12949446 chr17:45071677 GOSR2 G vs. A All: C 15 108,990 0.417 (G) 0.242 (A) 0.93 (0.90-0.96) 0 (0-50) 1.06e-05
rs12952596 chr17:45071685 GOSR2 A vs. G All: C 15 108,990 0.442 (A) 0.242 (G) 0.93 (0.90-0.96) 0 (0-50) 1.03e-05
rs12938690 chr17:45075365 GOSR2 A vs. G All: C 15 108,990 0.442 (A) 0.233 (G) 0.93 (0.90-0.96) 0 (0-51) 1.24e-05
rs2316329 chr17:45080048 GOSR2 G vs. A All: C 15 108,990 0.408 (G) - 1.10 (1.05-1.14) 0 (0-26) 1.42e-05
rs6416935 chr17:60184914 MED13 [+42271bp] G vs. T All: C 15 108,990 - - 0.91 (0.87-0.95) 12 (0-50) 3.27e-05
rs11657294 chr17:60186535 MED13 [+43892bp] G vs. A All: C 15 108,990 - - 0.91 (0.87-0.95) 11 (0-48) 4.01e-05
rs7210244 chr17:60187719 MED13 [+45076bp] A vs. G All: C 15 108,990 0.117 (A) - 1.10 (1.05-1.15) 16 (0-53) 4.23e-05
rs8067362 chr17:60187986 MED13 [+45343bp] C vs. T All: C 15 108,990 - - 0.91 (0.87-0.95) 15 (0-53) 4.27e-05
rs6504084 chr17:60188441 MED13 [+45798bp] A vs. G All: C 15 108,990 0.117 (A) 0.5 (A) 1.10 (1.05-1.15) 16 (0-54) 4.19e-05
rs148534175 chr17:60198200 intergenic C vs. T All: C 15 108,990 - - 0.92 (0.88-0.96) 33 (0-64) 8.08e-05
rs74894391 chr17:60198760 intergenic G vs. A All: C 15 108,990 0.1 (G) 0.358 (G) 1.10 (1.05-1.15) 32 (0-64) 9.43e-05
rs4522464 chr17:60199130 intergenic G vs. T All: C 15 108,990 0.1 (G) 0.35 (G) 1.09 (1.05-1.14) 33 (0-64) 8.46e-05
rs2376585 chr17:76417883 PGS1 T vs. C All: C 15 108,990 0.225 (T) 0.042 (T) 0.92 (0.88-0.96) 0 (0-32) 2.94e-04
rs4969188 chr17:76422473 DNAH17 T vs. C All: C 15 108,990 0.258 (T) 0.042 (T) 0.92 (0.88-0.96) 0 (0-33) 5.75e-05
rs341237 chr18:6401283 L3MBTL4 T vs. C All: C 15 108,990 0.333 (T) 0.442 (T) 0.94 (0.91-0.97) 52 (13-73) 6.37e-05